Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sorafenib in Conjunction With Chemotherapy and as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

NCT00726986 is registered in ClinicalTrials.gov with Afshin Dowlati, MD as lead sponsor.

NCT NCT00726986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00726986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sorafenib in Conjunction With Chemotherapy and as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
Lead sponsor
Afshin Dowlati, MD
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2008
Completion date
July 31, 2012
Enrollment
18 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer